Guidance & Forms

A-Z Index

Browse this A-Z index to gain access toHRPO prioritytopics. The links will connect you directly to the guidelines, forms, checklists, training, and resources you need. For any topic that might be missing from this index, please email the IRB office at askirb@pitt.edu.

• A

  • Acknowledgement of Unregulated Research Activities
  • Activities Not Under the Pitt IRB Jurisdiction
  • Adverse Events Log (download doc)
  • Advertisements
  • Audit by Federal Agency

• B

  • Belmont Report
  • Blood Drawings for Human Subject Research

• C

  • Certificate of Confidentiality NIH
  • Children in Research
  • Child Clearances
  • Children's Online Privacy Protection Act (COPPA)
  • CITI Training
  • ClinicalTrials.gov
  • Cohort Discovery
  • Common Rule [45 CFR 46]
  • Common Rule 2018
  • Continuing Review - OHRP Guidance
  • Coordinating Center Applications and Responsibilities
  • Coordinating Center Application (download)
  • COVID-19 Human Subject Research FAQ
  • COVID-19 Information Sheet for Participants
  • COVID-19: Research Participant Screening Questions

  Consent Guidance

  • Guidance/Suggested Wording
  • Child Research Signature Lines
  • Consent Forms in Medical Records
  • Family Members Information
  • Key Information
  • Low Literacy and Disabled Participants
  • Not Reasonably Available
  • Reconsent
  • Short Form Consent Documents
  • UPMC Cost Language

• D

  • Data and Safety Monitoring Plan
  • Data and Safety Monitoring Board/Committee
  • Data Management-University Guidelines
  • Data Security Assessment Form
    • Data SecurityAssessment Form (helpful tips)
  • Data Security Guidance
  • Data Security-Pitt Information Technology
  • Data Use Agreement (DUA)
  • Decedent Research
  • Decisional Impairment Checklist
  • Declaration of Helsinki
  • Department of Defense (DOD) Checklist
  • Device (PittPRO)
  • Drug Evaluation and Research - FDA Guidance
  • Drug (PittPRO)
    • Drug - IND Determination

• E

  • Electronic Signatures

  Emergency Use (EU)

  • EU Consent Template
  • Expanded Access Drug or Biologic FDA
  • Expanded Access Medical Device FDA
  • Engagement of Institutions in Human Subjects Research
  • Exempt Review (2018 Revised Rule)
  • Expedited Review Categories OHRP
  • External Pathway

• F

  • Faculty Mentor Responsibilities
  • FDA: Medical Devices
  • FDA: Medical Apps
  • FDA: Drugs
  • FDA: Good Clinical Practice
  • FDA: Guidance for IRBs, Clinical Investigators, and Sponsors
  • FDA: Decisions for Investigational Device Exemption Clinical Investigations(issued 8.19.2014)
  • FDA: MedWatch
  • Family Educational Rights and Privacy Act (FERPA)
  • Federal Wide Assurance -DHHS
  • Federal Wide Assurance (FWA) and Engaged in Research
  • Finder's Fees and Payments to Research and Clinical Staff

• G

  • Genetic Information Nondiscrimination Act (GINA)
  • Genomic Repository Guidance (dbGaP/Other NIH-designated)
  • GDPR (European Union General Data Protection Regulation)
  • Guidelines for Researchers Returning to UPMC Facilities

• H

  • HIPAA
  • HIPAA Checklist
  • HIPAA Checklist: Example Language
  • HIPAA Authorization and Decedent Research
  • HIPAA Privacy Rule - Databases and Research Repositories - NIH Guidance
  • HIPAA Privacy Rule Information for IRBs - NIH Guidance
  • HIPAA Privacy Rule Information for Researchers - NIH Guidance
  • Honest Broker
  • Honest Broker Assurance Form

• I

  • Industry-Sponsored Fee Information (or Fee Form download)
  • Innovative Practice
  • Institutional Review Boards-FDA [21 CFR Part 56]
  • Internet and Human Subject Research - DHHS
  • International Compilation of Human Research Standards
  • International Research
  • Introductory Script Sample

• J

• K

  • Key Information in Consent Form

• L

  • Leaving the University Checklist
  • Log for Adverse Events
  • Log for Noncompliance / Deviations

• M

  • Material Transfer Agreements (MTA)
  • Memo of Cultural Appropriateness
  • Mobile Medical Device-FDA
  • Mobile App-IRB Review
  • Modifications

• N

  • Non-English Speaking Participants
  • Noncompliance/Deviation Log

• O

  • Off-Label Drugs and Biologics
  • OSIRIS to PittPRO (IRB application system)

• P

  • Paper Submission Forms
  • Payment Procedure for Human Subjects - Vincent

  PittPRO Information

  • Drug Section
  • IND Determination
  • Device Section
  • Protection of Pupil Rights Amendment (PPRA)
  • Prisoners: OHRP Guidance on the Involvement of Prisoners in Research
  • Privacy and Confidentiality for Research Participants
  • Protection of Human Subjects (FDA) 21 CFR 50

• Q

  • Quality Improvement Activities FAQ - OHRP

• R

  • Radiation Guidance
  • Research Restart Survey
  • Returning to UPMC Facilities: Guidelines for Researchers

  Reliance Guidance

  • Individual Investigator Agreement (IIA)
  • IRB Fee Sheet
  • Overview of Reliance Request System Content
  • Pitt Cede IRB Review
  • Pitt IRB of Record

  Reportable New Information

  • Reportable New Information FAQs
  • Log for Adverse Events
  • Log for Noncompliance / Deviations

• S

  • Short Form Consent Documents
  • Site Permission Letter
  • Student Researchers
  • Study Status

• T

  • Telephone Screening Script
  • Tip Sheet for OSIRIS Conversions
  • Transition of Data Analysis Only and Long Term Follow Up to PittPRO
  • Translator Certification Form

• U

  • UPMC Fiscal Form
  • Returning to UPMC Facilities: Guidelines for Researchers

• V

  • Visitors on Campus (Academic and Research)

• W

• X

• Y

• Z